medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 5

<< Back Next >>

Ann Hepatol 2017; 16 (5)

Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis

Cooper CL, Thavorn K, Damian E, Corsi DJ

Language: English
References: 20
Page: 720-726
PDF size: 230.40 Kb.


ABSTRACT

Introduction and aim. HCV-infected immigrants contribute to the total prevalence in Canada and other developed nations. Little is known about engagement in care, access to service, and treatment outcomes in recipients of Direct Acting Antiviral (DAA) HCV therapies among immigrants living with HCV. Material and methods. HCV patients assessed at The Ottawa Hospital Viral Hepatitis Clinic between 2000-2016 were identified. Immigration history, race, socioeconomic status, HCV work-up, treatment and outcome data were evaluated. HCV fibrosis assessment, treatment and sustained virologic response (SVR) were compared using logistic regression. Results. 2,335 HCV-infected patients were analyzed with 91% (2114) having data on immigration (23% immigrants). A median 16 years (Quartiles: 5, 29) passed from immigration to referral. Access to diagnostic procedures (Fibroscan/liver biopsy) was greater among immigrants compared to Canadian-born (78% vs. 68%, p = 0.001) and immigrants had an odds ratio of 1.72 (95% CI: 1.18-2.51) of receiving a FibroScan compared to Canadians after adjustment for demographic characteristics, HCV risk factors, and socioeconomic status. No differences in SVR were found between immigrants for IFN recipients. Among DAA recipients, rates of SVR were › 94% among all patients, 93% in Canadian-born and 98% among immigrants (p = 0.14). Conclusion. Nearly 80% of immigrants in this setting had access to fibrosis assessment which was higher than Canadian-born patients. Under half of both groups had initiated HCV therapy. Delays in accessing HCV care represent a missed opportunity to engage, treat and cure HCV patients. HCV screening and health care engagement at the time of immigration would optimize HCV care and therapeutic outcomes.


REFERENCES

  1. Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. Canada Communicable Disease Report 2014; 40: 429.

  2. Statistics Canada: Immigration and Ethnocultural Diversity in Canada, National Household Survey, 2011. In. Ottawa: Statistics Canada, 2013.

  3. Census: Immigration in Canada: A portrait of the Foreignborn population. 2006. Available at: http:// www.census2006.ca/census-recensement/2006/assa/97- 557/index-eng.cfm.

  4. Greenaway C, Thu Ma A, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I. The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. PLoS One 2015; 10: e0141715. doi: 10.1371/ journal.pone.0141715.

  5. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-67. doi: 10.1016/S1473-3099(05)70216-4.

  6. Boyd M, Vickers M. 100 years of immigration in Canada. Canadian Social Trends 2000; 58 (Fall): 2-12.

  7. Newbold KB. Chronic conditions and the healthy immigrant effect: evidence from Canadian immigrants. J Ethnic and Migration Studies 2006; 32: 765-84.

  8. Ku L, Matani S. Left out: immigrants' access to health care and insurance. Health Aff (Millwood) 2001; 20: 247-56.

  9. Giordano C, Druyts EF, Garber G, Cooper C. Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes. Eur J Gastroenterol Hepatol 2009; 21: 963-8. doi: 10.1097/MEG.0b013e328326f598.

  10. Wilkins R. Postal code conversion file plus (PCCF+), version 5F: automated geographic coding based on the Statistics Canada Postal Code Conversion files, including postal codes through July 2009. Ottawa, ON: Health Statistics Division, Statistics Canada, 2010.

  11. Pampalon R, Hamel D, Gamache P, Philibert MD, Raymond G, Simpson A. An area-based material and social deprivation index for public health in Quebec and Canada. Can J Public Health 2012; 103: S17-S22.

  12. Pampalon R, Hamel D, Gamache P, Raymond G. A deprivation index for health planning in Canada. Chronic Dis Can 2009; 29: 178-91.

  13. StataCorp: Stata Statistical Software: release 14.1 SE. In. College Station, TX: Stata Corp., 2015.

  14. McDonald JT, Kennedy S. Insights into the 'healthy immigrant effect': health status and health service use of immigrants to Canada. Soc Sci Med 2004:59:1613-27. doi: 10.1016/ j.socscimed.2004.02.004.

  15. Vang ZM, Sigouin J, Flenon A, Gagnon A. Are immigrants healthier than native-born Canadians? A systematic review of the healthy immigrant effect in Canada. Ethn Health 2016; 1-33. doi: 10.1080/13557858.2016.1246518.

  16. Le Lan C, Guillygomarch A, Danielou H, Le Dreau G, Laine F, Vedeilhie C, Deugnier Y, et al. A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcoholdependent patients with ongoing abuse. J Hepatol 2012; 56: 334-40. doi: 10.1016/j.jhep.2011.05.021.

  17. Bos V, Kunst AE, Garssen J, Mackenbach JP. Socioeconomic inequalities in mortality within ethnic groups in the Netherlands, 1995-2000. J Epidemiol Community Health 2005; 59: 329-35. doi: 10.1136/jech.2004.019794.

  18. Blakely T, Subramanian SV. Multilevel Studies. In: Oakes JM, Kaufman JS (Eds.). Methods in Social Epidemiology. San Fransisco: Jossey-Bass, 2006; 316-40.

  19. Diez Roux AV. Next steps in understanding the multilevel determinants of health. J Epidemiol Community Health 2008; 62: 957-9. doi: 10.1136/jech.2007.064311.

  20. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57. doi: 10.1016/ j.jhep.2014.07.027.




2020     |     www.medigraphic.com